Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07535242) titled 'Serum GFAP, NfL, VEGF and Clinical Progression in Progressive MS' on April 3.
Study Type: Observational
Primary Sponsor: Ondokuz Mayis University
Condition:
Multiple Sclerosis
Recruitment Status: Not recruiting
Date of First Enrollment: April 21, 2026
Target Sample Size: 22
To know more, visit https://clinicaltrials.gov/study/NCT07535242
Published by HT Digital Content Services with permission from Health Daily Digest....